Механічна тромбекстракція в пацієнтки з гострим ішемічним інсультом на тлі антикоагулянтної терапії

В.О. Ярош, В.В. Бабенко, О.Є. Свиридюк, О.Й. Жарінов, О.А. Єпанчінцева, Б.М. Тодуров

Література

1. Albers G.W., Marks M.P., Kemp S. et al. DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging // New Engl. J. Med.– 2018.– Vol. 378.– P. 708–718. doi: 10.1056/NEJMoa1713973.
2. Bejot Y., Ben Salem D., Osseby G.V. et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 // Neurology.– 2009.– Vol. 72.– P. 346–353. doi: 10.1212/01.wnl.0000341280.31919.bd.
3. Diener H.C., Connolly S.J., Ezekowitz M.D. et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial // Lancet Neurol.– 2010.– Vol. 9 (12).– P. 1157–1163. doi: 10.1016/S1474-4422(10)70274-X.
4. Easton J.D., Lopes R.D., Bahit M.C. et al. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial // Lancet Neurol.– 2012.– Vol. 11.– P. 503–511. doi: 10.1016/S1474-4422(12)70092-3.
5. Emberson J., Lees K.R., Lyden P. et al.; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials // Lancet.– 2014.– Vol. 384.– P. 1929–1935. doi: 10.1016/S0140-6736(14)60584-5.
6. Freedman B., Martinez C., Katholing A., Rietbrock S. Residual risk of stroke and death in anticoagulant‐treated patients with atrial fibrillation // JAMA Cardiol.– 2016.– Vol. 1.– P. 366–368. doi: 10.1001/jamacardio.2016.0393.
7. Gupta A.C., Schaefer P.W., Chaudhry Z.A. et al. Interobserver reliability of baseline noncontrast CT Alberta Stroke Program Early CT Score for intra-arterial stroke treatment selection // Am. J. Neuroradiol.– 2012.– Vol. 33 (6).– P. 1046–1049. doi: 10.3174/ajnr.A2942.
8. Hacke W., Kaste M., Bluhmki E. et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke // New Engl. J. Med.– 2008.– Vol. 359.– P. 1317–1329. doi: 10.1056/NEJMoa0804656.
9. Hankey G.J., Patel M.R., Stevens S.R. et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of ROCKET AF // Lancet Neurol.– 2012.– Vol. 11.– P. 315–322. doi: 10.1016/S1474-4422(12)70042-X.
10. L’Allinec V., Sibon I., Mazighi M. et al. MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists // Neurology.– 2020.– Vol. 94 (8).– P. e842–e850. doi: 10.1212/WNL.0000000000008873.
11. Mozaffarian D., Benjamin E.J., Go A.S. et al. Heart disease and stroke statistics —2015 update: a report from the American Heart Association // Circulation.– 2015.– Vol. 131.– P. e29–322. doi: 10.1161/CIR.0000000000000350.
12. Nogueira R.G., Jadhav A.P., Haussen D.C. et al.; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct // New Engl. J. Med.– 2018.– Vol. 378 (1).– P. 11–21. doi: 10.1056/NEJMoa1706442.
13. Powers W.J., Rabinstein A.A., Ackerson T. et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association // Stroke.– 2019.– Vol. 50.– P. e344–e418. doi: 10.1161/STR.0000000000000211. 
14. Rost N.S., Giugliano R.P., Ruff C.T. et al. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) // Stroke.– 2016.– Vol. 47.– P. 2075–2082.
15. Seiffge D.J., Werring D.J., Paciaroni M. et al. Timing of anticoagulation after recent schaemic stroke in patients with atrial fibrillation // Lancet Neurol.– 2019.– Vol. 18.– P. 117–126. doi: 10.1161/STROKEAHA.116.013540. 
16. The top 10 causes of death: factsheet. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
17. Thomalla G., Simonsen C.Z., Boutitie F. et al; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset // New Engl. J. Med.– 2018.– Vol. 379.– P. 611–622. doi: 10.1056/NEJMoa1804355.
18. Vranckx P., Valgimigli M., Heidbuchel H. The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation // Arrhythm. Electrophysiol. Rev.– 2018.– Vol. 7 (1).– P. 55–61. doi:10.15420/aer.2017.50.1.